# Recombinase Polymerase Amplification (RPA): Principles and Applications

## Introduction to Recombinase Polymerase Amplification

### What is RPA?

Recombinase polymerase amplification (RPA) is an [isothermal nucleic acid amplification](/knowledge/diagnostics/molecular/isothermal-nucleic-acid-amplification) technology that enables the rapid, sensitive, and specific amplification of DNA targets without the thermal cycling required by conventional [Polymerase Chain Reaction](/knowledge/molecular-biology/polymerase-chain-reaction). Developed in the early 2000s, RPA harnesses the natural cellular machinery of [homologous recombination](/knowledge/molecular-biology/homologous-recombination)—specifically, the proteins involved in DNA strand exchange—to drive primer annealing and polymerase extension at a constant temperature, typically between 37°C and 42°C.

The fundamental innovation of RPA lies in its use of a recombinase enzyme that forms a nucleoprotein filament with oligonucleotide primers. This filament actively scans double-stranded DNA (dsDNA) for homologous sequences, invades the duplex, and facilitates strand displacement, allowing a polymerase to extend the primer without the need for heat-mediated denaturation. The entire reaction can proceed in as little as 5 to 20 minutes, making RPA one of the fastest nucleic acid amplification methods available.

RPA fits within the broader landscape of isothermal amplification technologies, which also includes [loop-mediated isothermal amplification](/knowledge/diagnostics/molecular/lamp-assay-rapid-detection-african-swine-fever-virus-oral-fluids) (LAMP), nucleic acid sequence-based amplification (NASBA), and strand displacement amplification (SDA). What distinguishes RPA from these methods is its operational simplicity: it requires only a single constant temperature, does not need a separate denaturation step, and can function effectively at near-physiological temperatures. This makes RPA exceptionally well-suited for point-of-care diagnostics, field-deployable testing, and resource-limited settings where sophisticated laboratory equipment is unavailable.

### RPA vs. PCR: Key Differences

The most obvious distinction between RPA and PCR is thermal cycling. PCR relies on repeated cycles of denaturation (typically 94–98°C), annealing (50–65°C), and extension (72°C) to amplify DNA exponentially. Each cycle requires precise temperature transitions, which demand a thermocycler—an instrument that is relatively expensive, consumes significant power, and is impractical for field use. In contrast, RPA operates at a single, constant temperature, eliminating the need for thermal cycling equipment entirely. A simple heat block, water bath, or even body heat can sustain the reaction.

The enzymatic machinery also differs fundamentally. PCR uses a thermostable DNA polymerase, such as [Taq Polymerase an Enzyme](/knowledge/molecular-biology/taq-polymerase-an-enzyme), which remains active at high temperatures but requires primers to anneal to single-stranded templates generated by heat denaturation. RPA, by contrast, employs a recombinase (typically the RecA/Rad51 family protein UvsX from bacteriophage T4), single-stranded DNA binding proteins (SSBs), and a strand-displacing polymerase (such as the large fragment of Bacillus subtilis DNA polymerase I, or Bsu polymerase). These proteins work together to unwind the dsDNA and synthesize new strands at a constant low temperature.

Another key difference lies in reaction speed and primer design. PCR typically requires 30–40 cycles, taking 1–3 hours to complete. RPA achieves comparable amplification in 5–20 minutes. However, RPA primers are generally longer than PCR primers (30–35 nucleotides versus 18–25 nucleotides) and require careful design to avoid secondary structures. Additionally, RPA amplicons are usually kept short (under 500 base pairs, ideally 100–200 bp) because the recombinase filament is less efficient at invading longer targets.

Finally, the detection formats differ. PCR products are commonly analyzed by gel electrophoresis, real-time fluorescence with intercalating dyes or hydrolysis probes, or sequencing. RPA products can be detected by similar methods, but the isothermal nature of the reaction allows for simpler, more portable detection strategies, including lateral flow strips and colorimetric readouts, which are difficult to integrate with PCR due to its high-temperature requirements.

## Core Components and Mechanism of RPA

### Recombinase and Strand Exchange

The central player in RPA is the recombinase enzyme. In the most widely used RPA formulations, this is the UvsX protein from bacteriophage T4. UvsX is a member of the RecA/Rad51 family of recombinases, which catalyze [homologous recombination](/knowledge/molecular-biology/homologous-recombination)—the exchange of genetic information between two DNA molecules with similar sequences. In the context of RPA, UvsX performs a similar function: it binds to single-stranded DNA (ssDNA) primers in the presence of ATP, forming a nucleoprotein filament.

The assembly of this filament is a critical step. UvsX monomers cooperatively bind to the primer DNA, coating it in a helical arrangement. This binding requires ATP, which is hydrolyzed to ADP during the strand exchange process. The nucleoprotein filament then searches the dsDNA template for a sequence complementary to the primer. This search is a three-dimensional process, involving both sliding along the DNA and hopping between different regions of the molecule. When a homologous sequence is found, the filament invades the duplex, base-pairing the primer with its complementary strand and displacing the non-complementary strand in a process called D-loop formation.

The efficiency of strand exchange depends on several factors. The primer must be sufficiently long to provide a stable nucleation site—typically 30–35 nucleotides for optimal RPA performance. Shorter primers (e.g., 20 nucleotides) can work but often result in reduced amplification efficiency. The GC content of the primer also matters; a balanced GC content (40–60%) promotes stable base-pairing without promoting excessive secondary structure. Additionally, the presence of ATP is essential, as it provides the energy for filament assembly and strand exchange. Most RPA reactions include ATP in the reaction buffer, often in a concentration of 2–3 mM.

After strand invasion, the displaced strand is stabilized by single-stranded binding proteins, which prevent it from re-annealing to the template. This allows the polymerase to access the primer-template junction and begin extension.

### Primer Design and Requirements

Primer design is arguably the most critical factor determining RPA success. Unlike PCR, where primers are typically 18–25 nucleotides long, RPA primers are longer, usually 30–35 nucleotides. This length is necessary because the UvsX recombinase filament requires a minimum length of approximately 30 nucleotides to form a stable nucleoprotein complex and efficiently invade the dsDNA template.

Several additional design rules apply:

- **Amplicon size**: Keep the target region short. RPA works best with amplicons of 100–200 base pairs, though products up to 500 bp can be amplified with reduced efficiency. Longer amplicons require more time for the recombinase to scan and invade, and the polymerase must processively synthesize longer stretches, which increases the likelihood of premature termination.
- **Primer melting temperature (Tm)**: Because RPA operates at 37–42°C, primers should have a Tm in the range of 50–70°C. However, the effective annealing is mediated by the recombinase, not by thermal melting, so Tm calculations are less predictive than in PCR. Still, avoiding extreme GC content (below 30% or above 70%) is advisable.
- **Avoid secondary structures**: Primers with internal hairpins or self-dimers can sequester the recombinase and reduce amplification efficiency. Similarly, primer-dimers between forward and reverse primers should be avoided. Software tools such as Primer-BLAST can be adapted for RPA primer design, though dedicated RPA design programs (e.g., TwistDx's proprietary software) are often more reliable.
- **5' end modifications**: The 5' end of RPA primers can be modified with tags (e.g., biotin, FAM, or digoxigenin) for downstream detection. These modifications do not interfere with the recombinase-mediated strand invasion, as the filament assembly initiates at the 3' end.

It is worth noting that RPA primer design is not purely computational. Empirical testing is often required, as the three-dimensional structure of the target DNA and local sequence context can influence recombinase efficiency. Students should expect to screen multiple primer pairs before identifying one that works robustly.

### Role of SSB and Polymerase

Two additional protein components are essential for RPA: single-stranded DNA binding proteins (SSBs) and a strand-displacing DNA polymerase.

**Single-stranded binding proteins**: In the standard RPA formulation, the SSB is the gp32 protein from bacteriophage T4. gp32 binds cooperatively to single-stranded DNA, coating it in a manner that prevents secondary structure formation and protects it from nucleases. In the context of RPA, gp32 serves two critical functions. First, it stabilizes the displaced strand during D-loop formation, preventing it from re-annealing to the template. Second, it sequesters the single-stranded regions that are transiently exposed during strand exchange, ensuring that the polymerase can access the primer-template junction without competition from the displaced strand.

**Strand-displacing polymerase**: The polymerase used in RPA is typically the large fragment of *Bacillus subtilis* DNA polymerase I (Bsu polymerase). This enzyme lacks 5'→3' exonuclease activity but possesses strong strand displacement activity, meaning it can synthesize DNA while displacing the downstream strand. This property is essential because RPA does not involve a separate denaturation step; the polymerase must synthesize through the region where the complementary strand is still base-paired to the template.

The Bsu polymerase also lacks 3'→5' proofreading activity, which means it has a relatively high error rate compared to proofreading polymerases used in high-fidelity PCR. However, for most diagnostic and detection applications, this is not a significant concern, as the goal is to amplify a specific target, not to generate a high-fidelity clone. For applications requiring sequence accuracy, the amplified product can be subcloned and sequenced, or a proofreading polymerase can be used in a subsequent PCR step.

The complete RPA reaction also includes a crowding agent (typically polyethylene glycol, PEG 20,000), which creates a macromolecular crowding environment that mimics the intracellular milieu and promotes protein-DNA interactions. The reaction buffer contains Tris-acetate (pH 7.5–8.0), magnesium acetate (typically 14 mM), dNTPs (200 µM each), ATP (2–3 mM), and an ATP regeneration system (phosphocreatine and creatine kinase) to maintain ATP levels throughout the reaction.

## Optimization of RPA Reactions

### Temperature and Reaction Kinetics

RPA operates optimally at a constant temperature between 37°C and 42°C. The exact optimal temperature depends on the specific enzyme formulation and the target sequence. Most commercial RPA kits (e.g., TwistAmp from TwistDx) are optimized for 39°C. At this temperature, the reaction proceeds rapidly, with detectable amplification occurring within 5–10 minutes and reaching a plateau by 20–30 minutes.

The temperature dependence of RPA reflects the balance between several competing processes. At lower temperatures (below 37°C), the recombinase filament assembly is slower, and the strand exchange reaction proceeds less efficiently. At higher temperatures (above 42°C), the proteins begin to denature, and the stability of the primer-template duplex decreases. The narrow optimal temperature range means that precise temperature control is important, though the tolerance is still much greater than in PCR, where a 1–2°C deviation can significantly affect specificity.

Reaction kinetics follow a characteristic sigmoidal curve. During the initial lag phase (0–2 minutes), the recombinase filament assembles and searches for the target sequence. This is followed by an exponential phase (2–15 minutes) during which amplification proceeds logarithmically. Finally, the reaction reaches a plateau as substrates (dNTPs, ATP) are depleted and product concentration inhibits further amplification. The total reaction time is typically 20–40 minutes, though most of the amplification occurs within the first 15 minutes.

### Primer and Probe Design Considerations

Beyond the basic primer design rules discussed earlier, several additional considerations can improve RPA performance:

- **Primer concentration**: RPA reactions typically use primer concentrations of 400–500 nM each. This is higher than in PCR (typically 200–500 nM) but reflects the need to saturate the recombinase with primer substrate. Excessive primer concentrations (above 1 µM) can lead to non-specific amplification and primer-dimer formation.
- **Probe design for real-time detection**: For real-time RPA, a probe is required. The most common probe format is the exo probe, which contains a fluorophore and a quencher separated by a tetrahydrofuran (THF) spacer. The probe is designed to bind to the target sequence between the forward and reverse primers. When the probe hybridizes to the target, the THF spacer is cleaved by a nuclease (e.g., *E. coli* exonuclease III, Exo III), separating the fluorophore from the quencher and generating a fluorescent signal. The probe is typically 46–52 nucleotides long, with the fluorophore and quencher positioned 15–30 nucleotides apart.
- **Avoiding sequence repeats**: Primers and probes should not contain long runs of a single nucleotide (e.g., poly-A or poly-G stretches), as these can promote non-specific interactions and secondary structure formation.

### Enhancing Sensitivity and Specificity

Several strategies can enhance the sensitivity and specificity of RPA:

- **Nested RPA**: In this approach, an initial RPA reaction amplifies a larger region, and a second RPA reaction uses internal primers to amplify a smaller sub-region. This two-step approach increases sensitivity and specificity but doubles the reaction time.
- **Addition of formamide or DMSO**: These additives can reduce secondary structure in GC-rich templates, improving primer access. However, they must be used at low concentrations (1–5%) to avoid inhibiting the recombinase.
- **Optimization of magnesium concentration**: Magnesium is essential for recombinase activity and polymerase function. The standard concentration is 14 mM, but titration from 10–20 mM can improve amplification for specific targets.
- **Carrier RNA or DNA**: Adding carrier nucleic acids (e.g., yeast tRNA at 50–100 ng/µL) can reduce non-specific adsorption of primers and proteins to tube surfaces, improving reaction efficiency.

## Detection Methods for RPA Products

### Real-Time RPA with Exo Probes

Real-time RPA is the most versatile detection method, allowing continuous monitoring of amplification without post-reaction processing. The exo probe system, described above, is the most widely used format. The reaction is performed in a fluorometer or a portable real-time instrument capable of maintaining a constant temperature and measuring fluorescence at regular intervals.

The exo probe is a single-stranded oligonucleotide that contains an internal THF spacer flanked by a fluorophore (e.g., FAM) and a quencher (e.g., BHQ-1). When the probe is free in solution, the fluorophore and quencher are in close proximity, and fluorescence is quenched. When the probe hybridizes to the target sequence during amplification, the THF spacer becomes a substrate for Exo III, which cleaves the probe. This cleavage separates the fluorophore from the quencher, resulting in a fluorescence signal that increases with each amplification cycle.

Real-time RPA offers several advantages: it provides quantitative data (the time to threshold, or Tt, correlates with initial target copy number), eliminates the need for post-amplification handling (reducing contamination risk), and allows multiplexing by using probes with different fluorophores. However, it requires specialized equipment and is more expensive than endpoint detection methods.

### Lateral Flow Detection

Lateral flow detection is a simple, equipment-free method for detecting RPA products. In this approach, the forward primer is labeled with a hapten (e.g., FAM) and the reverse primer is labeled with biotin. After amplification, the RPA product contains both labels. A small volume of the reaction (typically 2–5 µL) is applied to a lateral flow strip, which contains:

1. A sample pad where the reaction is applied.
2. A conjugate pad containing gold nanoparticle-labeled anti-hapten antibodies (e.g., anti-FAM antibodies).
3. A nitrocellulose membrane with two test lines: one containing streptavidin (to capture biotin-labeled products) and one containing anti-rabbit IgG (as a control).
4. An absorbent pad that wicks the liquid through the strip.

As the sample migrates, the gold-labeled anti-FAM antibodies bind to the FAM-labeled RPA product. This complex then binds to the streptavidin line via the biotin label, producing a visible red line. A second line (the control) confirms that the strip is functioning correctly. The entire detection process takes 5–10 minutes and requires no instrumentation.

Lateral flow detection is ideal for point-of-care diagnostics and field applications, as it provides a visual, qualitative readout that can be interpreted by non-specialists. However, it is less quantitative than real-time RPA and requires careful optimization to avoid false positives from primer-dimers.

### Agarose Gel Analysis

Agarose gel electrophoresis is the simplest and most accessible method for detecting RPA products, though it is not the most sensitive. After the RPA reaction, a 5–10 µL aliquot is mixed with loading dye and run on a 1.5–2% agarose gel containing a DNA intercalating dye (e.g., ethidium bromide or GelRed). The expected product appears as a distinct band at the predicted size.

There are several important caveats when analyzing RPA products by gel electrophoresis. First, RPA reactions contain high concentrations of proteins (recombinase, SSB, polymerase), which can interfere with gel loading and migration. To address this, the reaction can be treated with proteinase K (20 mg/mL for 10 minutes at 37°C) before loading. Second, RPA products are often heterogeneous in size due to the strand displacement mechanism, which can produce smeared bands. This is normal and does not necessarily indicate non-specific amplification. Third, the reaction buffer contains high concentrations of salts and PEG, which can cause distortion of the gel bands. Diluting the reaction 1:10 in water before loading can mitigate this issue.

For students, gel electrophoresis remains a valuable tool for verifying RPA amplification, particularly when optimizing primer pairs or troubleshooting failed reactions. However, for quantitative or high-throughput applications, real-time or lateral flow detection is preferred.

## Applications of RPA in Research and Diagnostics

### Infectious Disease Diagnostics

The most prominent application of RPA is in the detection of infectious diseases, particularly in resource-limited settings where PCR is impractical. RPA has been developed for a wide range of pathogens, including:

- **Viruses**: HIV, hepatitis B and C viruses, influenza, Zika virus, dengue virus, and SARS-CoV-2. For RNA viruses, RPA is coupled with a reverse transcription step (RT-RPA), where a reverse transcriptase is added to the reaction to convert RNA to cDNA before amplification.
- **Bacteria**: *Mycobacterium tuberculosis*, *Salmonella* spp., *[Listeria monocytogenes](/knowledge/bacteria/livestock-bacteria/listeria-monocytogenes-circling-disease-ruminants-silage)*, *Neisseria meningitidis*, and *Chlamydia trachomatis*.
- **Parasites**: *Plasmodium* spp. (malaria), *Trypanosoma* spp., and *Leishmania* spp.

The key advantage of RPA in this context is its compatibility with simple sample preparation methods. Crude lysates, blood, saliva, and swab samples can be added directly to the reaction without extensive DNA purification, as the RPA enzymes are relatively tolerant of inhibitors that would inactivate PCR. This makes RPA suitable for use in mobile clinics, rural health centers, and low-income countries.

### Food Safety and Environmental Monitoring

RPA is also used for detecting foodborne pathogens and environmental contaminants. In food safety, RPA assays have been developed for *Salmonella*, *E. coli* O157:H7, *Campylobacter jejuni*, and *Vibrio parahaemolyticus*. The speed of RPA (under 30 minutes from sample to result) is particularly valuable in food processing facilities, where rapid screening can prevent contaminated products from reaching consumers.

In environmental monitoring, RPA has been used to detect waterborne pathogens, harmful algal blooms, and genetically modified organisms (GMOs) in agricultural products. The portability of RPA makes it suitable for on-site testing in remote or field locations, where samples cannot be transported to a central laboratory.

### CRISPR-Cas Combined Assays

A recent and exciting development is the combination of RPA with [CRISPR-Cas systems](/knowledge/molecular-biology/crispr-cas-system) for nucleic acid detection. In these assays, RPA is used to amplify the target sequence, and a Cas enzyme (e.g., Cas12a or Cas13) is then used to specifically recognize the amplified target and cleave a reporter molecule, generating a signal.

The most well-known example is the SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) system, which uses RPA for pre-amplification followed by Cas13-mediated detection. Similarly, the DETECTR (DNA Endonuclease-Targeted CRISPR Trans Reporter) system uses RPA followed by Cas12a detection. These combined assays achieve attomolar sensitivity and single-base specificity, making them powerful tools for detecting mutations, distinguishing closely related species, and identifying antimicrobial resistance genes.

The integration of RPA with CRISPR-Cas systems has also enabled the development of field-deployable diagnostic platforms that combine the speed and simplicity of RPA with the specificity of CRISPR-based detection. These platforms are being developed for applications ranging from infectious disease diagnosis to cancer mutation detection.

## Advantages and Limitations of RPA

### Advantages Over PCR

RPA offers several distinct advantages over PCR:

1. **Isothermal operation**: No thermal cycler is required. A simple heat block, water bath, or even body heat (for some formulations) can sustain the reaction. This dramatically reduces equipment cost and power requirements.
2. **Speed**: RPA amplifies DNA in 5–20 minutes, compared to 1–3 hours for PCR. This is critical in time-sensitive applications such as intraoperative diagnostics or outbreak response.
3. **Portability**: The reagents can be lyophilized (freeze-dried) and stored at room temperature for extended periods, eliminating the cold chain required for PCR reagents. This makes RPA ideal for field deployment.
4. **Tolerance to inhibitors**: RPA enzymes are more tolerant of common [PCR inhibitors](/knowledge/diagnostics/molecular/pcr-inhibitors-sources-detection-and-removal-strategies) (e.g., heme, humic acid, and certain detergents) than [Taq polymerase](/knowledge/molecular-biology/taq-polymerase-an-enzyme). This allows direct amplification from crude samples without extensive purification.
5. **Low energy consumption**: The absence of thermal cycling reduces energy requirements, enabling battery-powered operation in remote settings.

### Challenges and Pitfalls

Despite its advantages, RPA has several limitations:

1. **Primer design complexity**: RPA primers are longer and more constrained than PCR primers, and the design rules are less well-established. Empirical screening of multiple primer pairs is often necessary.
2. **Cost**: RPA reagents are more expensive than PCR reagents on a per-reaction basis, primarily due to the cost of the recombinant proteins (UvsX, gp32, Bsu polymerase). This can be a barrier for large-scale screening applications.
3. **Contamination risk**: Because RPA is isothermal and does not involve denaturation, the amplified product can serve as a template for further amplification if the reaction tube is opened. This creates a high risk of carryover contamination, particularly in laboratories that also perform PCR.
4. **Limited multiplexing**: While multiplex RPA is possible, it is more challenging than multiplex PCR due to the risk of primer-primer interactions and the limited availability of compatible fluorophores for real-time detection.
5. **Amplicon size limitation**: RPA is inefficient for amplifying fragments longer than 500 bp, which limits its use for applications requiring large amplicons (e.g., cloning or sequencing of long genomic regions).
6. **Error rate**: The Bsu polymerase lacks proofreading activity, resulting in an error rate of approximately 10⁻⁴ to 10⁻⁵ per base pair. This is acceptable for detection but not for applications requiring high-fidelity amplification.

## Common Pitfalls and Troubleshooting in RPA

### Primer Design Mistakes

The most common cause of RPA failure is poor primer design. Common mistakes include:

- **Primers too short**: Primers shorter than 28 nucleotides often fail to form stable recombinase filaments, resulting in no amplification. Always design primers of 30–35 nucleotides.
- **Primer-dimers**: Complementary regions between the forward and reverse primers can lead to primer-dimer amplification, which consumes reagents and produces non-specific products. Check for complementarity at the 3' ends of the primer pair.
- **Secondary structures**: Primers with internal hairpins (stem-loop structures) can sequester the recombinase and reduce amplification efficiency. Use software to predict secondary structures and avoid primers with strong hairpins (ΔG < −2 kcal/mol).
- **Amplicon too long**: Attempting to amplify fragments longer than 500 bp often results in weak or no amplification. If a longer amplicon is required, consider using a nested RPA approach.

### Reaction Failure Causes

If an RPA reaction fails to produce any product, consider the following:

- **Incorrect temperature**: RPA is temperature-sensitive. Verify that the reaction is incubated at 37–42°C. Temperatures below 35°C or above 45°C will significantly reduce activity.
- **Insufficient ATP**: ATP is required for recombinase activity. If using a homemade RPA formulation, ensure that ATP is included at 2–3 mM and that an ATP regeneration system (phosphocreatine and creatine kinase) is present.
- **Degraded reagents**: The recombinant proteins in RPA kits are sensitive to freeze-thaw cycles and prolonged storage. Store reagents at −20°C and avoid repeated freeze-thawing.
- **Inhibitory samples**: Some sample matrices (e.g., blood, soil) contain inhibitors that can reduce RPA efficiency. Dilute the sample (1:10 or 1:100) or purify the nucleic acid before amplification.
- **Incorrect magnesium concentration**: Magnesium is essential for recombinase and polymerase activity. If using a homemade formulation, titrate magnesium acetate from 10–20 mM to find the optimal concentration.

### Contamination Prevention

Contamination is a major concern in RPA, as the amplified product can serve as a template for subsequent reactions. To minimize contamination:

- **Physical separation**: Perform RPA setup in a dedicated area, separate from where RPA products are analyzed. Use separate pipettes and filter tips.
- **AmpErase (UNG) treatment**: If using dUTP instead of dTTP in the reaction, uracil-N-glycosylase (UNG) can be added to degrade contaminating amplicons before the reaction starts. However, this is not standard in commercial RPA kits.
- **Avoid opening reaction tubes**: Use real-time detection or lateral flow strips that can be read without opening the tube. If gel electrophoresis is required, open the tube in a fume hood and treat the product with proteinase K before analysis.
- **Use lyophilized reagents**: Lyophilized RPA pellets reduce the risk of contamination during setup, as they require only the addition of water and sample.

## Summary and Key Takeaways

Recombinase polymerase amplification is a powerful isothermal nucleic acid amplification technology that has transformed the landscape of molecular diagnostics. By harnessing the natural processes of homologous recombination and strand displacement, RPA achieves rapid, sensitive, and specific amplification of DNA targets at a constant temperature, eliminating the need for thermal cycling equipment.

The core components of RPA—the recombinase (UvsX), single-stranded binding proteins (gp32), and a strand-displacing polymerase (Bsu)—work in concert to drive primer annealing and extension. Primer design is critical, with optimal primers being 30–35 nucleotides long and amplicons kept under 500 base pairs. RPA reactions are typically performed at 37–42°C for 20–40 minutes, with detection achieved through real-time fluorescence (exo probes), lateral flow strips, or agarose gel electrophoresis.

RPA has found widespread applications in infectious disease diagnostics, food safety, environmental monitoring, and CRISPR-Cas combined assays. Its advantages—speed, portability, isothermal operation, and tolerance to inhibitors—make it ideal for point-of-care and field-deployable testing. However, challenges remain, including primer design complexity, reagent cost, contamination risk, and limited amplicon size.

For students studying molecular biology, understanding RPA provides insight into how natural cellular processes can be repurposed for biotechnology applications. The principles underlying RPA—recombinase-mediated strand exchange, single-stranded DNA binding, and strand-displacing synthesis—are fundamental concepts in DNA metabolism that extend far beyond this specific technique.

## Frequently Asked Questions

### What is recombinase polymerase amplification (RPA)?

Recombinase polymerase amplification (RPA) is an isothermal nucleic acid amplification technique that uses a recombinase enzyme to facilitate primer annealing to double-stranded DNA, followed by strand-displacing polymerase extension. The reaction operates at a constant temperature (37–42°C) and can amplify DNA targets in 5–20 minutes without thermal cycling.

### How does RPA differ from PCR?

RPA differs from PCR in several key ways: it operates at a single constant temperature rather than requiring thermal cycling; it uses a recombinase and single-stranded binding proteins to mediate primer annealing rather than heat denaturation; it employs a strand-displacing polymerase rather than a thermostable polymerase; and it is generally faster (5–20 minutes versus 1–3 hours). RPA also requires longer primers (30–35 nucleotides) and produces shorter amplicons (typically under 500 bp).

### What are the key components of an RPA reaction?

The key components are: (1) a recombinase (UvsX from bacteriophage T4) that forms nucleoprotein filaments with primers and mediates strand invasion; (2) single-stranded binding proteins (gp32) that stabilize displaced strands; (3) a strand-displacing DNA polymerase (Bsu polymerase) that synthesizes new DNA; (4) ATP and an ATP regeneration system; (5) primers (30–35 nucleotides); (6) dNTPs; (7) magnesium acetate; and (8) a crowding agent (PEG 20,000) in a buffered solution.

### What is the optimal temperature for RPA?

The optimal temperature for RPA is typically 37–42°C, with most commercial kits optimized for 39°C. The reaction can tolerate a range of approximately 35–45°C, but temperatures outside this range significantly reduce activity.

### How are RPA products detected?

RPA products can be detected by: (1) real-time fluorescence using exo probes (fluorophore-quencher probes cleaved by exonuclease III during amplification); (2) lateral flow strips, where labeled primers (e.g., FAM and biotin) produce a visible line on a test strip; (3) agarose gel electrophoresis, though this requires proteinase K treatment and is less sensitive; and (4) colorimetric methods using pH-sensitive dyes or DNA-intercalating dyes.

### What are common reasons for RPA failure?

Common reasons include: poorly designed primers (too short, forming dimers or secondary structures); amplicons too long (>500 bp); incorrect temperature; insufficient ATP or magnesium; degraded reagents; inhibitory sample components; and contamination with previously amplified products.

### Can RPA be used for RNA detection?

Yes. RPA can be coupled with reverse transcription (RT-RPA) to detect RNA targets. A reverse transcriptase (e.g., AMV or M-MLV reverse transcriptase) is added to the RPA reaction, converting RNA to cDNA before amplification. RT-RPA has been used to detect RNA viruses such as SARS-CoV-2, influenza, and Zika virus.

## Key Takeaways

- RPA is an isothermal amplification method that operates at 37–42°C, eliminating the need for thermal cycling equipment and enabling rapid (5–20 minute) DNA amplification.
- The reaction relies on three core proteins: a recombinase (UvsX) for strand invasion, single-stranded binding proteins (gp32) for stabilizing displaced strands, and a strand-displacing polymerase (Bsu) for DNA synthesis.
- RPA primers are 30–35 nucleotides long, and amplicons should be kept under 500 base pairs for optimal efficiency.
- Detection methods include real-time fluorescence with exo probes, lateral flow strips, and agarose gel electrophoresis, each with distinct trade-offs in sensitivity, cost, and equipment requirements.
- RPA is widely used in infectious disease diagnostics, food safety testing, environmental monitoring, and CRISPR-Cas combined assays, particularly in point-of-care and field settings.
- Key limitations include complex primer design, higher reagent cost compared to PCR, contamination risk, and limited multiplexing capability.
- Troubleshooting RPA failures should focus on primer design, reaction temperature, reagent integrity, and sample purity before considering more complex optimization strategies.

## Further Reading

- Lobato IM, O'Sullivan CK. *Recombinase polymerase amplification: Basics, applications and recent advances*. Trends in analytical chemistry : TRAC. 2018. [PubMed 32287544](https://doi.org/10.1016/j.trac.2017.10.015)
- Tan M et al. *Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications*. Frontiers in cellular and infection microbiology. 2022. [PubMed 36519130](https://doi.org/10.3389/fcimb.2022.1019071)
- Munawar MA. *Critical insight into recombinase polymerase amplification technology*. Expert review of molecular diagnostics. 2022. [PubMed 35950726](https://doi.org/10.1080/14737159.2022.2109964)
- Daher RK et al. *Recombinase Polymerase Amplification for Diagnostic Applications*. Clinical chemistry. 2016. [PubMed 27160000](https://doi.org/10.1373/clinchem.2015.245829)
- Feng X et al. *Recombinase Polymerase Amplification-Based Biosensors for Rapid Zoonoses Screening*. International journal of nanomedicine. 2023. [PubMed 37954459](https://doi.org/10.2147/IJN.S434197)
- Babu B, Ochoa-Corona FM, Paret ML. *Recombinase polymerase amplification applied to plant virus detection and potential implications*. Analytical biochemistry. 2018. [PubMed 29408177](https://doi.org/10.1016/j.ab.2018.01.021)

## Related Topics

- [RPA DNA Amplification](/knowledge/molecular-biology/rpa-dna-amplification)
- [RPA Isothermal Amplification](/knowledge/molecular-biology/rpa-isothermal-amplification)
- [Annealing Temperature Steel](/knowledge/molecular-biology/annealing-temperature-steel)


<div data-calculator="toxicity"></div>

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)